Physician Research Network Brings a Unique Value Proposition to Both Pharmaceutical Companies and Physicians
 |
|
|
|
|
|
|
 |
|
CLINICAL TRIALS
Since 2002, PRN has been engaged in management of phase 2, phase 3 and phase 4 drug and device clinical trials according to the GCP-ICH guidelines. Also, the HIPAA requirements to protect the confidentiality of protected health information (PHI) have been and will be incorporated at all clinical sites. A list of completed or ongoing clinical trials along with sponsors during the last 3 years is shown below:
| CLINICAL TRIALS DURING THE YEAR 2000: |
| Sponsor |
Indication |
| Alcon |
Pterygium (I) |
| Alcon |
Pterygium (II) |
| Bristol Myers-Squibb |
Hypertension |
| Glaxo Wellcome |
Irritable Bowel Syndrome (I) |
| Glaxo Wellcome |
Irritable Bowel Syndrome (II) |
| Merck |
Osteo-arthritis |
| Merck |
Low Back Pain |
| Novartis |
Irritable Bowel Syndrome |
| Searle |
Ankle Sprain |
| Senju Pharmaceuticals |
Bacterial Conjunctivitis |
| Solvay |
Irritable Bowel Syndrome(I) |
| Solvay |
Irritable Bowel Syndrome (II) |
| CLINICAL TRIALS DURING THE YEAR 2001: |
| Sponsor |
Indication |
| Abbott Laboratories |
Non-Epileptic Seizures |
| Bayer Pharmaceuticals |
Sinusitis |
| G.D. Searle & Co |
Hypertension |
| Genaissance Pharmaceuticals |
Hypercholesterolemia |
| Pro Med Dx |
Hepatitis B Virus (HBV) |
| Wyeth-Ayerst |
Depression |
| CLINICAL TRIALS DURING THE YEAR 2002: |
| Sponsor |
Indication |
| Aventis |
Asthma |
| Aventis |
Diabetes-Type I |
| Aventis |
Severe Asthma |
| EXACT Sciences |
Colorectal Cancer |
| Forest Pharmaceuticals |
Depression |
| Integrated Research |
Hypertension |
| Merck |
Rotavirus- Vaccination |
| Neuro Biosciences |
Insomnia |
| Novartis |
Atopic Dermatitis (I) |
| Novartis |
Atopic Dermatitis (II) |
| Novartis |
Asthma |
| Novartis |
Diabetes |
| Novartis |
Osteo-arthritis |
| Otsuka |
Peripheral Arterial Disease |
| Paragon Biomedical |
Depression |
| Pharmacia |
Acute Ankle Sprain |
| Pharmacia |
Osteo-arthritis of the Knee |
| Solvay |
Irritable Bowel Syndrome |
|
|
|
| CLINICAL TRIALS DURING THE YEAR 2003: |
| Sponsor |
Indication |
| Glaxo Smith-Kline |
Pediatric Asthma |
| ICON Research |
Pneumonia and Sepsis |
| ICON Research |
Pediatric Diabetes (II) |
| Kendle |
Adolescent Asthma |
| Neurocrine Biosciences |
Insomnia (II) |
| Parexel |
Diarrhea (C.difficle related) |
| PRA International |
Peripheral Arterial Disease |
| Quintiles |
Diabetes Type II Edema |
| Quintiles |
Post-Operative Pain
(CoronaryArtery By-pass Graft related) |
| Solvay Pharmaceuticals |
Atrial Flutter Fibrillation |
| TAP Pharmaceuticals |
Gout |
|
